Miscellaneous

PPD Completes New Leadership Appointments in Global Move

Monday, January 7, 2008 07:23 AM

Wilmington, N.C.-based contract research organization (CRO) PPD continues revamping its global operations with the appointment of Sebastian Pacios, M.D., hired to lead—as a senior vice president—the CRO’s European, Middle East and Africa operations.

More... »

Gout Drug Shows Promise in Two Pivotal Trials

Friday, January 4, 2008 01:24 PM

Savient Pharmaceuticals reported positive results from two phase III trials, GOUT 1 [Gout Outcomes and Uric acid Treatment] and GOUT 2, of Puricase, a pegylated recombinant urate oxidase for the treatment of gout. The disease is caused by the deposit of urate crystals (via uric acid) in the body's tissues such as joints, tendons and organs. Most traditional treatments have centered on blocking the production of uric acid in the body, whereas Puricase attempts to reduce the levels of uric acid in the blood stream.

More... »

Dissuasion in Recruitment Research

Wednesday, January 2, 2008 11:04 AM

Of all the techniques considered for affecting the behavior of patients and encouraging their clinical trial participation, nary a single researcher has considered the benefits of dissuasion. It is true on its face the concept seems a bit counterintuitive. After all, typical recruitment approaches involve persuasion, enticement, inducement and have, during less proud times, inched closer toward undue influence. What has not yet been explored is the benefit of dissuasion, or discouraging participants from refusing to participate in voluntary clinical research.

More... »

eClinical Technology News

Wednesday, December 26, 2007 06:54 AM

• New York, N.Y.-based Medidata Solutions electronic data capture (EDC) won an agreement with Boston, Mass.-based CRO Parexel through the Medidata’s non-exclusive service provider model, ASPire to win. Medidata stated the CRO was attracted to Rave’s broad user acceptance, ease of deployment and real-time access to clinical data. Medidata Solutions also landed a contract with Dublin-based Elan Pharmaceuticals for the technology company’s Medidata Rave solution. Medidata stated that much of Elan’s data management operations is outsourced so it needed a product that could be easily adopted by any CRO regardless of past experience with the technology. Elan will use the solution for mid-to-late stage trials in North America.

More... »

AAHRPP Accredits Final Batch of Organizations for 2007

Thursday, December 20, 2007 01:21 PM

The Association for the Accreditation of Human Research Protection Programs (AAHRPP) accredited its final 11 organizations for the year.

More... »

CenterWatch Monthly December 2007 Issue

Monday, December 17, 2007 09:58 AM

Asia-Pacific Countries Set for Global Clinical Project Leadership

More... »

Recent Industry Personnel Changes

Monday, December 17, 2007 07:57 AM

Contract Research

More... »

CWWeekly December 10th 2007 Issue

Friday, December 14, 2007 09:51 AM

Top News

More... »

PRA International Completes Buyout

Thursday, December 13, 2007 12:58 PM

Genstar Capital, a private equity group based in San Francisco, has completed its acquisition of PRA International, paying $797 million for the Raleigh, N.C.-based contract research organization (CRO).

More... »

Premier Consolidates Expertise into One Consulting Unit

Wednesday, December 12, 2007 11:37 AM

Philadelphia, Pa.-based Premier Research Group has consolidated its experts, including therapeutic leadership, medical device development, adaptive clinical trials design, and clinical trial informatics, into a single consulting group called Strategic Product Development (SPD) that will be led by Samer Kaba,M.D., vice president of SPD and global medical affairs.

More... »